PIK-108

Modify Date: 2024-01-07 11:19:37

PIK-108 structure	Common Name	PIK-108
	CAS Number	901398-68-3	Molecular Weight	364.44
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₂H₂₄N₂O₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of PIK-108

PIK-108 is a non-ATP competitive, allosteric p110β/p110δ selective inhibitor[1].

Name	PIK-108

Description	PIK-108 is a non-ATP competitive, allosteric p110β/p110δ selective inhibitor[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> PI3K/Akt/mTOR >> PI3K
In Vitro	PIK-108 (0.1-10 μM; 1 hour) blocks phosphorylation of PKB/Akt[1]. Western Blot Analysis[1] Cell Line: Glioma cell lines expressing wild-type PTEN Concentration: 0.1, 0.5, 1, 4, and 10 μM Incubation Time: 1 hour Result: Showed variable inhibition of PKB/Akt phosphorylation but exhibited a trend toward reducing PKB/Akt phosphorylation more effectively in mutant PTEN-expressing cell lines than in wild-type PTEN-expressing cell lines.
References	[1]. Zachary A Knight, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47. [2]. Jack S Chen, et al. Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma. Mol Cancer Ther. 2008 Apr;7(4):841-50.

Molecular Formula	C₂₂H₂₄N₂O₃
Molecular Weight	364.44